About the AuthorMy name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
My ProfileI am an authority on regulatory aspects of communications and medical products, with particular emphasis on pre-approval communications; strategist to help pharma and biotech companies prepare best case for advisory committee approval; and counselor in issues and crisis management. I am a frequent speaker on various aspects of same - drug development, promotion, reimbursement and new media in a highly regulated environment. Author of books, newspaper and magazine pieces related to drug marketing and promotion as well as HIV specialty pieces. And of course... blogger!
About This Blog
Eye on FDA is published by Mark Senak of FleishmanHillard’s New York office. The thoughts and ideas in this blog and postings are strictly my own and are not screened by my employer. Everything posted on this blog is my personal opinion and does not necessarily represent the views of FleishmanHillard or its clients.
Posts by Date
Monthly Archives: September 2006
I had the week off and it went by quickly. Once AlItalia screwed up my vacation, I stayed home and organized my house. It wasn’t as much fun as Italy, but profoundly reassuring. I had fun with Nick and Nora … Continue reading
A short posting today – I’m on vacay. But I thought it worthwhile to bring to your attention that the Century Foundation has started a bi-weekly collection of the best of healthcare blogs over the past two weeks. It is … Continue reading
Nanotechnology seems to be creeping up on us. The FDA is paying attention. Earlier this year, the FDA announced plans for a meeting on the topic of nanotechnology. The notice defined it as: "Nanotechnology is described by the National Nanotechnology … Continue reading
In the wake of the IOM report last week, I thought it worthy to examine some of the reasons for a disconnect between what is expressed by "the establishment" and what beliefs are formed by the general population. It is … Continue reading
In what was top-line news on Friday, the Institute of Medicine (IOM) released a report entitled "The Future of Drug Safety: Promoting and Protecting the Health of the Public", requested by the FDA about the FDA. While the conclusions of … Continue reading